Tag: IN EVIDENCE

Brain-computer interfaces now carry a four-hundred-billion-dollar valuation and a few dozen patients who can type by thought. The distance between ...

A shingles vaccine keeps turning up, study after study, beside a lower risk of dementia. The signal is now strong ...

The evidence that chronic ambient sound is restructuring the brain has been building for a decade. Medicine has been slow ...

The pharmaceutical supply chain was designed for a world in which geopolitics was someone else's problem. That world is no ...

Four years after DeepMind solved protein structure prediction, the field has had time to assess the claim. The tool has ...

Circadian disruption is one of the more robust mechanisms connecting lifestyle to accelerated biological ageing. The molecular evidence is substantial. ...

A year-long randomized trial of low-dose rapamycin returned a quieter result than the longevity press has acknowledged.

The cardiovascular and mortality evidence on semaglutide and its class is now substantial in defined at-risk populations. Reading that as ...

The weight-loss story is the popular story. The metabolic and inflammatory story is more consequential — and less settled than ...

An executive order signed with a podcaster in the room and a quip about wanting some directs fifty million dollars ...

A humanoid robot ran 21 kilometres in under 51 minutes. The engineering is impressive. The claims attached to it require ...

The productivity case for AI in professional environments has been made emphatically. A 2026 study found the opposite effect for ...